| Summary of Changes in Shareholders' Deficit |
Changes in shareholders’ deficit for the three months ended June 30, 2025 and 2024 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, 2025 |
|
|
|
Common Shares |
|
|
Paid-in Capital in Excess of Par Value |
|
|
Accumulated Other Comprehensive Loss |
|
|
Accumulated Deficit |
|
|
Total Herbalife Shareholders’ Deficit |
|
|
Noncontrolling Interests |
|
|
Total Shareholders’ Deficit |
|
|
|
(in millions) |
|
Balance as of March 31, 2025 |
|
$ |
0.1 |
|
|
$ |
287.9 |
|
|
$ |
(266.4 |
) |
|
$ |
(757.6 |
) |
|
$ |
(736.0 |
) |
|
$ |
— |
|
|
$ |
(736.0 |
) |
Issuance of 2.1 common shares from exercise of SARs, restricted stock units, employee stock purchase plan, and other |
|
|
— |
|
|
|
0.6 |
|
|
|
|
|
|
|
|
|
0.6 |
|
|
|
|
|
|
0.6 |
|
Additional capital from share-based compensation |
|
|
|
|
|
10.4 |
|
|
|
|
|
|
|
|
|
10.4 |
|
|
|
|
|
|
10.4 |
|
Repurchases of 0.6 common shares |
|
|
— |
|
|
|
(4.6 |
) |
|
|
|
|
|
— |
|
|
|
(4.6 |
) |
|
|
|
|
|
(4.6 |
) |
Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
49.3 |
|
|
|
49.3 |
|
|
|
(0.1 |
) |
|
|
49.2 |
|
Foreign currency translation adjustment, net of income taxes of $0.2 |
|
|
|
|
|
|
|
|
24.2 |
|
|
|
|
|
|
24.2 |
|
|
|
|
|
|
24.2 |
|
Unrealized loss on derivatives, net of income taxes of $— |
|
|
|
|
|
|
|
|
(4.4 |
) |
|
|
|
|
|
(4.4 |
) |
|
|
|
|
|
(4.4 |
) |
Acquisition |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
6.2 |
|
|
|
6.2 |
|
Balance as of June 30, 2025 |
|
$ |
0.1 |
|
|
$ |
294.3 |
|
|
$ |
(246.6 |
) |
|
$ |
(708.3 |
) |
|
$ |
(660.5 |
) |
|
$ |
6.1 |
|
|
$ |
(654.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, 2024 |
|
|
|
Common Shares |
|
|
Paid-in Capital in Excess of Par Value |
|
|
Accumulated Other Comprehensive Loss |
|
|
Accumulated Deficit |
|
|
Total Shareholders’ Deficit |
|
|
|
(in millions) |
|
Balance as of March 31, 2024 |
|
$ |
0.1 |
|
|
$ |
244.2 |
|
|
$ |
(242.9 |
) |
|
$ |
(1,038.0 |
) |
|
$ |
(1,036.6 |
) |
Issuance of 1.2 common shares from exercise of SARs, restricted stock units, employee stock purchase plan, and other |
|
|
— |
|
|
|
0.8 |
|
|
|
|
|
|
|
|
|
0.8 |
|
Additional capital from share-based compensation |
|
|
|
|
|
11.8 |
|
|
|
|
|
|
|
|
|
11.8 |
|
Repurchases of 0.3 common shares |
|
|
— |
|
|
|
(3.4 |
) |
|
|
|
|
|
— |
|
|
|
(3.4 |
) |
Net income |
|
|
|
|
|
|
|
|
|
|
|
4.7 |
|
|
|
4.7 |
|
Foreign currency translation adjustment, net of income taxes of $0.1 |
|
|
|
|
|
|
|
|
(21.6 |
) |
|
|
|
|
|
(21.6 |
) |
Unrealized gain on derivatives, net of income taxes of $0.1 |
|
|
|
|
|
|
|
|
7.1 |
|
|
|
|
|
|
7.1 |
|
Balance as of June 30, 2024 |
|
$ |
0.1 |
|
|
$ |
253.4 |
|
|
$ |
(257.4 |
) |
|
$ |
(1,033.3 |
) |
|
$ |
(1,037.2 |
) |
Changes in shareholders’ deficit for the six months ended June 30, 2025 and 2024 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, 2025 |
|
|
|
Common Shares |
|
|
Paid-in Capital in Excess of Par Value |
|
|
Accumulated Other Comprehensive Loss |
|
|
Accumulated Deficit |
|
|
Total Herbalife Shareholders’ Deficit |
|
|
Noncontrolling Interests |
|
|
Total Shareholders’ Deficit |
|
|
|
(in millions) |
|
Balance as of December 31, 2024 |
|
$ |
0.1 |
|
|
$ |
278.2 |
|
|
$ |
(271.4 |
) |
|
$ |
(808.0 |
) |
|
$ |
(801.1 |
) |
|
$ |
— |
|
|
$ |
(801.1 |
) |
Issuance of 2.8 common shares from exercise of SARs, restricted stock units, employee stock purchase plan, and other |
|
|
— |
|
|
|
0.9 |
|
|
|
|
|
|
|
|
|
0.9 |
|
|
|
|
|
|
0.9 |
|
Additional capital from share-based compensation |
|
|
|
|
|
22.0 |
|
|
|
|
|
|
|
|
|
22.0 |
|
|
|
|
|
|
22.0 |
|
Repurchases of 0.9 common shares |
|
|
— |
|
|
|
(6.8 |
) |
|
|
|
|
|
— |
|
|
|
(6.8 |
) |
|
|
|
|
|
(6.8 |
) |
Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
99.7 |
|
|
|
99.7 |
|
|
|
(0.1 |
) |
|
|
99.6 |
|
Foreign currency translation adjustment, net of income taxes of $0.6 |
|
|
|
|
|
|
|
|
32.9 |
|
|
|
|
|
|
32.9 |
|
|
|
|
|
|
32.9 |
|
Unrealized loss on derivatives, net of income taxes of $— |
|
|
|
|
|
|
|
|
(8.1 |
) |
|
|
|
|
|
(8.1 |
) |
|
|
|
|
|
(8.1 |
) |
Acquisition |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
6.2 |
|
|
|
6.2 |
|
Balance as of June 30, 2025 |
|
$ |
0.1 |
|
|
$ |
294.3 |
|
|
$ |
(246.6 |
) |
|
$ |
(708.3 |
) |
|
$ |
(660.5 |
) |
|
$ |
6.1 |
|
|
$ |
(654.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, 2024 |
|
|
|
Common Shares |
|
|
Paid-in Capital in Excess of Par Value |
|
|
Accumulated Other Comprehensive Loss |
|
|
Accumulated Deficit |
|
|
Total Shareholders’ Deficit |
|
|
|
(in millions) |
|
Balance as of December 31, 2023 |
|
$ |
0.1 |
|
|
$ |
233.9 |
|
|
$ |
(232.0 |
) |
|
$ |
(1,062.3 |
) |
|
$ |
(1,060.3 |
) |
Issuance of 2.1 common shares from exercise of SARs, restricted stock units, employee stock purchase plan, and other |
|
|
— |
|
|
|
1.5 |
|
|
|
|
|
|
|
|
|
1.5 |
|
Additional capital from share-based compensation |
|
|
|
|
|
23.7 |
|
|
|
|
|
|
|
|
|
23.7 |
|
Repurchases of 0.6 common shares |
|
|
— |
|
|
|
(5.7 |
) |
|
|
|
|
|
— |
|
|
|
(5.7 |
) |
Net income |
|
|
|
|
|
|
|
|
|
|
|
29.0 |
|
|
|
29.0 |
|
Foreign currency translation adjustment, net of income taxes of $— |
|
|
|
|
|
|
|
|
(31.5 |
) |
|
|
|
|
|
(31.5 |
) |
Unrealized gain on derivatives, net of income taxes of $— |
|
|
|
|
|
|
|
|
6.1 |
|
|
|
|
|
|
6.1 |
|
Balance as of June 30, 2024 |
|
$ |
0.1 |
|
|
$ |
253.4 |
|
|
$ |
(257.4 |
) |
|
$ |
(1,033.3 |
) |
|
$ |
(1,037.2 |
) |
|
| Summary of Changes in Accumulated Other Comprehensive Loss |
The following table summarizes changes in accumulated other comprehensive loss by component during the three months ended June 30, 2025 and 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in Accumulated Other Comprehensive Loss by Component |
|
|
|
Three Months Ended |
|
|
|
June 30,
2025 |
|
|
June 30,
2024 |
|
|
|
Foreign Currency Translation Adjustments |
|
|
Unrealized Gain (Loss) on Derivatives |
|
|
Total |
|
|
Foreign Currency Translation Adjustments |
|
|
Unrealized (Loss) Gain on Derivatives |
|
|
Total |
|
|
|
(in millions) |
|
Beginning balance |
|
$ |
(273.6 |
) |
|
$ |
7.2 |
|
|
$ |
(266.4 |
) |
|
$ |
(240.5 |
) |
|
$ |
(2.4 |
) |
|
$ |
(242.9 |
) |
Other comprehensive income (loss) before reclassifications, net of tax |
|
|
24.2 |
|
|
|
(1.7 |
) |
|
|
22.5 |
|
|
|
(21.6 |
) |
|
|
6.6 |
|
|
|
(15.0 |
) |
Amounts reclassified from accumulated other comprehensive loss to income, net of tax(1) |
|
|
— |
|
|
|
(2.7 |
) |
|
|
(2.7 |
) |
|
|
— |
|
|
|
0.5 |
|
|
|
0.5 |
|
Total other comprehensive income (loss), net of reclassifications |
|
|
24.2 |
|
|
|
(4.4 |
) |
|
|
19.8 |
|
|
|
(21.6 |
) |
|
|
7.1 |
|
|
|
(14.5 |
) |
Ending balance |
|
$ |
(249.4 |
) |
|
$ |
2.8 |
|
|
$ |
(246.6 |
) |
|
$ |
(262.1 |
) |
|
$ |
4.7 |
|
|
$ |
(257.4 |
) |
(1)
See Note 9, Derivative Instruments and Hedging Activities, for information regarding the location within the condensed consolidated statements of income of gains (losses) reclassified from accumulated other comprehensive loss to income during the three months ended June 30, 2025 and 2024.
The following table summarizes changes in accumulated other comprehensive loss by component during the six months ended June 30, 2025 and 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in Accumulated Other Comprehensive Loss by Component |
|
|
|
Six Months Ended |
|
|
|
June 30,
2025 |
|
|
June 30,
2024 |
|
|
|
Foreign Currency Translation Adjustments |
|
|
Unrealized Gain (Loss) on Derivatives |
|
|
Total |
|
|
Foreign Currency Translation Adjustments |
|
|
Unrealized (Loss) Gain on Derivatives |
|
|
Total |
|
|
|
(in millions) |
|
Beginning balance |
|
$ |
(282.3 |
) |
|
$ |
10.9 |
|
|
$ |
(271.4 |
) |
|
$ |
(230.6 |
) |
|
$ |
(1.4 |
) |
|
$ |
(232.0 |
) |
Other comprehensive income (loss) before reclassifications, net of tax |
|
|
32.9 |
|
|
|
(1.3 |
) |
|
|
31.6 |
|
|
|
(31.5 |
) |
|
|
4.8 |
|
|
|
(26.7 |
) |
Amounts reclassified from accumulated other comprehensive loss to income, net of tax(1) |
|
|
— |
|
|
|
(6.8 |
) |
|
|
(6.8 |
) |
|
|
— |
|
|
|
1.3 |
|
|
|
1.3 |
|
Total other comprehensive income (loss), net of reclassifications |
|
|
32.9 |
|
|
|
(8.1 |
) |
|
|
24.8 |
|
|
|
(31.5 |
) |
|
|
6.1 |
|
|
|
(25.4 |
) |
Ending balance |
|
$ |
(249.4 |
) |
|
$ |
2.8 |
|
|
$ |
(246.6 |
) |
|
$ |
(262.1 |
) |
|
$ |
4.7 |
|
|
$ |
(257.4 |
) |
(1)
See Note 9, Derivative Instruments and Hedging Activities, for information regarding the location within the condensed consolidated statements of income of gains (losses) reclassified from accumulated other comprehensive loss to income during the six months ended June 30, 2025 and 2024.
|